Jul 28, 09:09
Jul 28, 09:07
Only BuyersOnly Buyers in Marksans Pharma on NSE
79% of moneycontrol users recommend buying Marksans Pharma.
What's your call on Marksans Pharma today?
Read 55 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2760.00||0.52||2939.80||2140.35||47,012.47|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Visaka Industries Recommended on Jun 16th 2014
Recommended price 101.00 | Peak from reco 133.55 31.71%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Marksans Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,263.81 crore.The company has reported a consolidated sales of Rs 168.75 crore and a Net Profit of Rs 22.99 crore for the quarter ended Dec 2013.
The company management includes Mark Saldanha - Chairman & Managing Director, B S Desai - Whole Time Director, S R Buddharaju - Director, Ajay S Joshi - Director, Naresh Balwant Wadhwa - Ind.& Non Exe.Director.
It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.
Its Registered office is at 11th Floor, Lotus Business Park,,Off New Link Road, Mumbai,Maharashtra - 400053.
Their Registrars are Bigshare Services Pvt. Ltd.